A potential new vaccine for COVID-19.  The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Scientists have concerns. They talk about a self-fulfilling prophecy – o2

Scientists believe the impressive advances in anti-aging, or anti-aging, research could meanThat…

Can you solve the math problem from “Millionaires”? That was the million dollar question

Questions from “Millionaires“It brings up a lot of emotions. Some people criticize…

Can mental toughness be learned? Scientists think so

The research has been published in one of the most respected scientific…

Discover the outermost galaxy. It’s called HD 1

HD1 is the farthest object in spacewhich we have noticed. Astronomers from…